NCT01388569View on ClinicalTrials.gov

Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

June 28, 2011

Primary Completion Date

September 28, 2011

Study Completion Date

September 28, 2011

Conditions
Melanoma (Skin)
Interventions
OTHER

flow cytometry

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT01388569 - Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim | Biotech Hunter | Biotech Hunter